Article
- The EMBO Journal (2002) 21, 4809 - 4819
- doi:10.1093/emboj/cdf499
Subject Categories:
Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line
Youjia Cao1, Erin M. Janssen2, Andrew W. Duncan1, Amnon Altman3, Daniel D. Billadeau4 and Robert T. Abraham5
- Department of Pharmacology and Cancer Biology, Duke University Medical Center, NC 27710, USA
- Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA
- Division of Cell Biology, La Jolla Institute of Allergy and Immunology, 10355 Science Center Drive, San Diego, CA 92121, USA
- Division of Developmental Oncology Research and Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA
- Program in Signal Transduction Research, The Burnham Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA
Correspondence to:
Robert T. Abraham, E-mail: abraham@burnham.org
Received 15 April 2002; Accepted 31 July 2002; Revised 23 July 2002
Abstract
The Rac/Rho-specific guanine nucleotide exchange factor, Vav-1, is a key component of the T-cell antigen receptor (TCR)-linked signaling machinery. Here we have used somatic cell gene-targeting technology to generate a Vav-1-deficient Jurkat T-cell line. The J.Vav1 cell line exhibits dramatic defects in TCR-dependent interleukin (IL)-2 promoter activation, accompanied by significant reductions in the activities of the NFAT(IL-2), NF
B, AP-1 and REAP transcription factors that bind to the IL-2 promoter region. In contrast, loss of Vav-1 had variable effects on early TCR-stimulated signaling events. J.Vav1 cells display a selective defect in sustained Ca2+ signaling during TCR stimulation, and complementation of this abnormality by exogenously introduced Vav-1 is dependent on the Vav-1 calponin homology domain. While JNK activation was severely impaired, the stimulation of Ras, ERK and protein kinase C-
activities, as well as the mobilization of lipid rafts, appeared normal in the J.Vav1 cells. Finally, evidence is presented to suggest that the alternative Vav family members, Vav-2 and Vav-3, are activated during TCR ligation, and partially compensate for the loss of Vav-1 in Jurkat T cells.
Keywords:
- protein kinase C-
, - signal transduction,
- T-cell antigen receptor,
- Vav
- protein kinase C-



